Xtant Medical Holdings (XTNT) Cash & Equivalents Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.76% |
| Sep 30, 2025 | 30.56% |
| Jun 30, 2025 | 18.06% |
| Mar 31, 2025 | 9.21% |
| Dec 31, 2024 | 3.43% |
| Sep 30, 2024 | 2.79% |
| Jun 30, 2024 | -5.97% |
| Mar 31, 2024 | -8.52% |
| Dec 31, 2023 | -3.41% |
| Sep 30, 2023 | 11.34% |
| Jun 30, 2023 | -7.31% |
| Mar 31, 2023 | -3.46% |
| Dec 31, 2022 | 48.03% |
| Sep 30, 2022 | 53.03% |
| Jun 30, 2022 | 58.19% |
| Mar 31, 2022 | 46.61% |
| Dec 31, 2021 | 47.90% |
| Sep 30, 2021 | 66.78% |
| Jun 30, 2021 | 55.73% |
| Mar 31, 2021 | 31.91% |
| Dec 31, 2020 | -18.14% |
| Sep 30, 2020 | -19.22% |
| Jun 30, 2020 | 8.30% |
| Mar 31, 2020 | 2.24% |
| Dec 31, 2019 | 3.23% |
| Sep 30, 2019 | -3.73% |
| Jun 30, 2019 | 19.61% |
| Mar 31, 2019 | 8.28% |
| Dec 31, 2018 | 17.41% |
| Sep 30, 2018 | 8.06% |
| Jun 30, 2018 | 3.33% |
| Mar 31, 2018 | 23.84% |
| Dec 31, 2017 | -10.33% |
| Sep 30, 2017 | -24.82% |
| Jun 30, 2017 | 6.53% |
| Mar 31, 2017 | 12.77% |
| Dec 31, 2016 | 27.97% |
| Sep 30, 2016 | -4.94% |
| Jun 30, 2016 | 9.60% |
| Mar 31, 2016 | 65.55% |
| Dec 31, 2015 | 81.04% |
| Sep 30, 2015 | 69.37% |
| Jun 30, 2015 | -8.32% |